TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE
6.1. Overview
6.2. Reagents and Kits
6.3. Instruments
6.3.1. Chemiluminescence
6.3.2. Immunofluorescence
6.3.3. ELISA
6.3.4. Immunochromatography
7. GLOBAL CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE
7.1. Overview
7.2. Troponin I and T
7.3. Creatine Kinase-MB
7.4. Brain Natriuretic Peptide
7.5. Myoglobin
7.6. High-sensitivity C-reactive Protein
7.7. Other Cardiac Biomarkers
8. GLOBAL CARDIAC MARKER TESTING MARKET, BY DISEASES
8.1. Overview
8.2. Myocardial Infarction
8.3. Congestive Heart Failure
8.4. Acute Coronary Syndrome
8.5. Atherosclerosis
8.6. Ischemia
9. GLOBAL CARDIAC MARKER TESTING MARKET, BY END USER
9.1. Overview
9.2. Laboratory Testing Facilities
9.2.1. Hospital Labs
9.2.2. Reference Labs
9.2.3. Contract Testing Labs
9.3. Point-Of-Care Testing Facilities
9.4. Academic Institutions
10. GLOBAL CARDIAC MARKER TESTING MARKET, BY REGION
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Cardiac Marker Testing Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Cardiac Marker Testing Market,
11.7. Key developments and Growth Strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2023
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Roche Diagnostics
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Abbott Laboratories
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Siemens Healthineers
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Beckman Coulter
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. BioMérieux
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Ortho Clinical Diagnostics
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Bio-Rad Laboratories
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. RANDOX LABORATORIES
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Products Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Thermo Fisher Scientific
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Products Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. BECTON, DICKINSON AND COMPANY
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Products Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL CARDIAC MARKER TESTING MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL CARDIAC MARKER TESTING MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 11 US: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 12 US: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 13 US: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 14 US: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 15 CANADA: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 16 CANADA: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 17 CANADA: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 18 CANADA: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 19 EUROPE: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 20 EUROPE: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 21 EUROPE: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 22 EUROPE: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 23 GERMANY: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 24 GERMANY: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 25 GERMANY: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 26 GERMANY: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 27 FRANCE: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 28 FRANCE: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 29 FRANCE: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 30 FRANCE: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 31 ITALY: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 32 ITALY: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 33 ITALY: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 34 ITALY: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 35 SPAIN: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 36 SPAIN: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 37 SPAIN: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 38 SPAIN: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 39 UK: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 40 UK: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 41 UK: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 42 UK: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 43 REST OF EUROPE: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 44 REST OF EUROPE: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 45 REST OF EUROPE: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 46 REST OF EUROPE: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 47 ASIA-PACIFIC: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 48 ASIA-PACIFIC: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 49 ASIA-PACIFIC: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 50 ASIA-PACIFIC: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 51 JAPAN: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 52 JAPAN: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 53 JAPAN: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 54 JAPAN: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 55 CHINA: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 56 CHINA: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 57 CHINA: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 58 CHINA: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 59 INDIA: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 60 INDIA: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 61 INDIA: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 62 INDIA: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 63 AUSTRALIA: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 64 AUSTRALIA: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 65 AUSTRALIA: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 66 AUSTRALIA: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 67 SOUTH KOREA: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 68 SOUTH KOREA: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 69 SOUTH KOREA: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 70 SOUTH KOREA: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 71 REST OF ASIA-PACIFIC: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 72 REST OF ASIA-PACIFIC: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 73 REST OF ASIA-PACIFIC: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 74 REST OF ASIA-PACIFIC: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 75 REST OF THE WORLD: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 76 REST OF THE WORLD: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 77 REST OF THE WORLD: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 78 REST OF THE WORLD: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 79 MIDDLE EAST: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 80 MIDDLE EAST: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 81 MIDDLE EAST: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 82 MIDDLE EAST: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 83 AFRICA: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 84 AFRICA: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 85 AFRICA: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 86 AFRICA: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 87 LATIN AMERICA: CARDIAC MARKER TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 88 LATIN AMERICA: CARDIAC MARKER TESTING MARKET, BY BIOMARKER TYPE, 2019-2032 (USD BILLION)
TABLE 89 LATIN AMERICA: CARDIAC MARKER TESTING MARKET, BY DISEASES, 2019-2032 (USD BILLION)
TABLE 90 LATIN AMERICA: CARDIAC MARKER TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL CARDIAC MARKER TESTING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL CARDIAC MARKER TESTING MARKET
FIGURE 4 GLOBAL CARDIAC MARKER TESTING MARKET, SHARE (%), BY PRODUCT TYPE, 2023
FIGURE 5 GLOBAL CARDIAC MARKER TESTING MARKET, SHARE (%), BY BIOMARKER TYPE, 2023
FIGURE 6 GLOBAL CARDIAC MARKER TESTING MARKET, SHARE (%), BY DISEASES, 2023
FIGURE 7 GLOBAL CARDIAC MARKER TESTING MARKET, SHARE (%), BY END USER, 2023
FIGURE 8 GLOBAL CARDIAC MARKER TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 NORTH AMERICA: CARDIAC MARKER TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 EUROPE: CARDIAC MARKER TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 ASIA-PACIFIC: CARDIAC MARKER TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 REST OF THE WORLD: CARDIAC MARKER TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 13 GLOBAL CARDIAC MARKER TESTING MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 14 ROCHE DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 ROCHE DIAGNOSTICS: SWOT ANALYSIS
FIGURE 16 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 ABBOTT LABORATORIES: SWOT ANALYSIS
FIGURE 18 SIEMENS HEALTHINEERS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 SIEMENS HEALTHINEERS: SWOT ANALYSIS
FIGURE 20 BECKMAN COULTER: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 BECKMAN COULTER: SWOT ANALYSIS
FIGURE 22 BIOMÉRIEUX.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 BIOMÉRIEUX.: SWOT ANALYSIS
FIGURE 24 ORTHO CLINICAL DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 ORTHO CLINICAL DIAGNOSTICS: SWOT ANALYSIS
FIGURE 26 BIO-RAD LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 BIO-RAD LABORATORIES: SWOT ANALYSIS
FIGURE 28 RANDOX LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 RANDOX LABORATORIES: SWOT ANALYSIS
FIGURE 30 THERMO FISHER SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS
FIGURE 32 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS
